AlphaYou
Overview
Key stats
Fundamentals Sep 13- Open
- $386.14
- 52-wk high
- $447.03
- High
- $386.99
- 52-wk low
- $262.49
- Low
- $377.22
- Prev close
- $382.47
- Mkt cap
- $204.01B
- P/E
- 23.8x
- Volume
- 2.27M
- Fwd P/E
- 15.7x
- Beta
- 0.43
- Div yield
- 2.56%
- P/S
- 5.4x
- P/B
- 17.7x
- Profit margin
- +23.0%
- Op margin
- +35.5%
- ROE
- +91.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 12.3% above what analysts expected.
Earnings per share
$5.60 expected
Revenue
No comparable estimate
FY2026 guidance
$38.20B to $39.40B
No comparable estimate
Reports Nov 3, 2026, in 51 days
EPS expected
$5.48 to $6.16
Revenue expected
24 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $9.56B | $9.90B | $8.62B | $10.05B |
| Cost of what it sold | $3.08B | $1.79B | $2.74B | $2.81B |
| Gross profit | $6.47B | $8.11B | $5.87B | $7.24B |
| What it spent | ||||
| Research and development | $1.90B | $2.15B | $1.72B | $1.87B |
| Sales and admin | $1.72B | $1.95B | $1.60B | $1.75B |
| Other operating costs | $329.0M | $61.0M | -$113.0M | $116.0M |
| Total operating expenses | $3.95B | $4.16B | $3.21B | $3.73B |
| What was left | ||||
| Operating profit | $2.53B | $3.94B | $2.67B | $3.51B |
| Interest on debt | $685.0M | $653.0M | $657.0M | $673.0M |
| Profit before tax | $3.92B | $1.51B | $2.08B | $2.77B |
| Tax | $705.0M | $181.0M | $265.0M | $393.0M |
| Net profit | $3.22B | $1.33B | $1.82B | $2.38B |
| EBITDA | $5.91B | $3.30B | $3.86B | $3.44B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Tone of tracked coverage
Amgen (AMGN) Dips More Than Broader Market: What You Should Know
NeutralSep 10Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
Leans bullishSep 10Sequoia Financial Advisors LLC Boosts Stock Holdings in Amgen Inc. $AMGN
Leans bullishSep 10National Pension Service Has $465.74 Million Stake in Amgen Inc. $AMGN
NeutralSep 10NewEdge Advisors LLC Has $33.69 Million Holdings in Amgen Inc. $AMGN
NeutralSep 10HSBC downgrades Amgen stock rating to Hold on valuation
Leans bearishSep 10Amgen, AstraZeneca combination improves survival measures in late-stage lung cancer study
BullishSep 9Amgen and AstraZeneca report survival improvement in lung cancer trial
BullishSep 9
Macro
32 macro signals shaping AMGN right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results